Maynard Um
-
-
-
-
-
-
-
Mizuho Upgrades Relmada Therapeutics Inc (RLMD) to Outperform
-
-
-
-
-
-
-
Relmada Therapeutics (RLMD) Tops Q2 EPS by 10c
-
-
-
-
-
-
-
Relmada Therapeutics (RLMD) Acquires Potential Therapy for Tourette Syndrome from Asarina Pharma AB
-
-
-
-
-
-
-
Jefferies Upgrades Relmada Therapeutics Inc (RLMD) to Buy
-
-
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

